Literature DB >> 19657231

HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1.

Keita Kirito1, Yongzhen Hu, Norio Komatsu.   

Abstract

Excessive reactive oxygen species (ROS) are toxic to hematopoietic cells. The majority of cellular ROS are derived from mitochondria and glucose metabolism, and cytokines stimulate this process. During hypoxia, hypoxia inducible factor-1 (HIF-1) attenuates hypoxia-induced mitochondrial ROS production through the induction of pyruvate dehydrogenase kinase-1 (PDK-1). Previously, we found that thrombopoietin (TPO) induces the generation of mitochondrial ROS. Interestingly, the TPO-induced production of mitochondrial ROS promotes the activation of HIF-1. Based on these findings, we speculated that TPO-activated HIF-1 functions as a feedback mechanism to block the overproduction of ROS following TPO stimulation. We found that TPO induces the expression of PDK-1 in a TPO-dependent cell line, UT-7/TPO, in a HIF-1-dependent manner. Inhibition of either HIF-1 or PDK-1 resulted in the increased production of ROS following TPO stimulation. Our observations suggest that HIF-1 functions as a ROS sensor to prevent the overproduction of mitochondrial ROS following cytokine stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657231     DOI: 10.4161/cc.8.17.9544

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

1.  CRISPR/Cas9 Edited Induced Pluripotent Stem Cell-Based Vascular Tissues to Model Aging and Disease-Dependent Impairment.

Authors:  Aylin Acun; Pinar Zorlutuna
Journal:  Tissue Eng Part A       Date:  2019-04-30       Impact factor: 3.845

2.  The stem cell niche: tissue physiology at a single cell level.

Authors:  Jonathan Hoggatt; David T Scadden
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

Review 3.  Many mechanisms mediating mobilization: an alliterative review.

Authors:  Jonathan Hoggatt; Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

4.  Perturbation of cellular oxidative state induced by dichloroacetate and arsenic trioxide for treatment of acute myeloid leukemia.

Authors:  Ashkan Emadi; Mariola Sadowska; Brandon Carter-Cooper; Vishal Bhatnagar; Isabella van der Merwe; Mark J Levis; Edward A Sausville; Rena G Lapidus
Journal:  Leuk Res       Date:  2015-04-30       Impact factor: 3.156

5.  Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.

Authors:  Zhiwen Liu; Xiaohui Jia; Yijie Duan; Huijie Xiao; Karl-Gösta Sundqvist; Johan Permert; Feng Wang
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

6.  Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration.

Authors:  Giuseppina Di Giacomo; Salvatore Rizza; Costanza Montagna; Giuseppe Filomeni
Journal:  Int J Cell Biol       Date:  2012-08-13

Review 7.  Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment.

Authors:  Jonathan Hoggatt; Louis M Pelus
Journal:  Stem Cell Res Ther       Date:  2011-03-14       Impact factor: 6.832

8.  Downregulation of the Werner syndrome protein induces a metabolic shift that compromises redox homeostasis and limits proliferation of cancer cells.

Authors:  Baomin Li; Juan Manuel Iglesias-Pedraz; Leng-Ying Chen; Fei Yin; Enrique Cadenas; Sita Reddy; Lucio Comai
Journal:  Aging Cell       Date:  2014-04       Impact factor: 9.304

Review 9.  Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate.

Authors:  Mark Frederick McCarty; Francisco Contreras
Journal:  Front Oncol       Date:  2014-09-16       Impact factor: 6.244

10.  HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer.

Authors:  Young-Suk Jung; Abdo J Najy; Wei Huang; Seema Sethi; Michael Snyder; Wael Sakr; Gregory Dyson; Maik Hüttemann; Icksoo Lee; Rouba Ali-Fehmi; Silvia Franceschi; Linda Struijk; Harold E Kim; Ikuko Kato; Hyeong-Reh Choi Kim
Journal:  Oncotarget       Date:  2017-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.